Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
The Neurohospitalist|June 23, 2026
Electronic Health Record-Based Estimates of Acute Disseminated Encephalomyelitis Epidemiology in a Large Healthcare Network, 2000-2025Alexandra Balshi, John P Dempsey, Yanli Zhang-James, et al.
International Journal of MS Care|March 4, 2021
Prevalence of Latent Tuberculosis in the Multiple Sclerosis Clinic and Effect of Multiple Sclerosis Treatment on Tuberculosis TestingAndrew J Bouley, Ursela Baber, Emily Egnor, et al.
Frontiers in Neurology|March 14, 2022
Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 TreatmentsKelli M Money, Ursela Baber, Emma Saart, et al.
Multiple Sclerosis and Related Disorders|March 5, 2026
Appendicitis and multiple sclerosis disease-modifying therapies: a disproportionality analysis of the FDA adverse event reporting systemAlexandra Balshi, Madelyn Esser, John P Dempsey, et al.
Neurology. Clinical Practice|June 13, 2025
Erratum: Herpes Zoster Infections With Multiple Sclerosis Disease-Modifying Therapies: A Real-World Pharmacovigilance StudyAlexandra Balshi, Grace Leuenberger, John Dempsey, et al.
Neurology. Clinical Practice|March 14, 2025
Herpes Zoster Infections With Multiple Sclerosis Disease-Modifying Therapies: A Real-World Pharmacovigilance StudyAlexandra Balshi, Grace Leuenberger, John Dempsey, et al.
Journal of Neurology|November 24, 2019
Correction to: Risk factors for lymphopenia in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarateFabian Sierra Morales, Igor J Koralnik, Shiva Gautam, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 16, 2024
Altered lymphocyte profiles and herpes zoster infections in patients with multiple sclerosis on natalizumabAlexandra Balshi, Nova Manning, John Dempsey, et al.
Journal of Neurology|February 22, 2025
A disproportionality analysis of surgical site infections across multiple sclerosis disease modifying therapiesAlexandra Balshi, John Dempsey, Nova Manning, et al.
Journal of Neurology|October 5, 2019
Risk factors for lymphopenia in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarateFabian Sierra Morales, Igor J Koralnik, Shiva Gautam, et al.
Pageof 6